Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°­µµº¯Á¶¹æ»ç¼±Ä¡·áÀÇ È¯ÀÚº° Á¤µµ°ü¸® : Çʸ§ ¼±·®°è ¹× ÃÖÀûÈ­¹ýÀ» ÀÌ¿ëÇÑ Á¤·®Àû Á¢±Ù Patient Specific Quality Assurance of IMRT : Quantitative Approach Using Film Dosimetry and Optimization

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2005³â 23±Ç 3È£ p.176 ~ 185
¼Ò¼Ó »ó¼¼Á¤º¸
½Å°æȯ/Shin KH ¹Ú¼º¿ë/¹Úµ¿Çö/½Åµ¿È£/¹Ú´Þ/±èÅÂÇö/ǥȫ·Ä/±èÁÖ¿µ/±è´ë¿ë/Á¶°üÈ£/Çã¼ø³ç/±èÀÏÇÑ/¹ÚÂùÀÏ/Park SY/Park DH/Shin DH/Park D/Kim TH/Pyo HR/Kim JY/Kim DY/Cho KH/Huh SN/Kim IH/Park CI

Abstract

¸ñ Àû: ȯÀÚº° °­µµº¯Á¶¹æ»ç¼±Ä¡·á Á¤µµ°ü¸®(IMRT QA) Áß Çʸ§ ¼±·®°è¸¦ ÀÓ»ó¿¡ Àû¿ëÇÏ°í, Çʸ§ µî¼±·®Áß½ÉÁ¡ Ä¡¿ìħ ±³Á¤ ÃÖÀûÈ­¹ýÀ» °³¹ßÇÏ¿´´Ù. ÃÖÀûÈ­ ÈÄ Çʸ§ ¼±·®°è¿¡ ´ëÇÑ Á¤·®Àû Çã¿ë±âÁصµ Á¦½ÃÇÏ°íÀÚ ÇÏ¿´´Ù.

´ë»ó ¹× ¹æ¹ý: IMRT Ä¡·á¸¦ ½ÃÇàÇϱâ·Î ÇÑ 14¸íÀÇ µÎ°æºÎÁ¾¾ç ȯÀÚ¿¡¼­ Çʸ§ ¼±·®°è¸¦ ½ÃÇàÇÏ°í, °¡Àå Å« °èÅëÀû ¿ÀÂ÷ ¿äÀÎÀÎ Çʸ§ µî¼±·®Áß½ÉÁ¡ Ä¡¿ìħ ±³Á¤ ÃÖÀûÈ­¹ýÀ» °í¾ÈÇÏ¿© Àû¿ëÇÏ¿´´Ù.

°á °ú: Çʸ§ ¼±·®°èÀÇ Çʸ§ µî¼±·®Áß½ÉÁ¡ Ä¡¿ìħ ±³Á¤ ÃÖÀûÈ­¹ýÀº local minimumÀ» ±¸ÇÏ´Â ¹æ½ÄÀ¸·Î °í¾ÈÇÏ¿´À¸¸ç, ȯÀÚ¿¡°Ô Àû¿ë ½Ã Á¶Á¤°ªÀº 2 mm¸¦ º¸ÀÎ 2¸íÀ» Á¦¿ÜÇÏ°í 12¸í¿¡¼­ 1 mm·Î ³ªÅ¸³µ´Ù. Çʸ§ µî¼±·®Áß½ÉÁ¡ Ä¡¿ìħ ±³Á¤ ÃÖÀûÈ­ ÀüÈÄ·Î ¼±·®¿ÀÂ÷ °á°ú¸¦ »êÃâÇÏ¿´À¸¸ç, ÃÖÀûÈ­ ÀüÈÄÀÇ Àý´ë Æò±Õ ¼±·®¿ÀÂ÷ÀÇ Æò±ÕÀº °¢°¢ 2.36%, 1.56%, Á¡¼±·®¿ÀÂ÷°¡ 5% ÀÌ»óÀÎ ÁöÁ¡ÀÇ ºñÀ²Àº Æò±ÕÀº °¢°¢ 9.67%, 2.88%·Î¼­ ÃÖÀûÈ­ ÈÄ ¼±·®¿ÀÂ÷°¡ ÇöÀúÈ÷ °¨¼ÒÇÏ¿´´Ù. ÃÖÀûÈ­ ÈÄ Àý´Ü Àú¼±·® ¿µ¿ªÀ» ¼³Á¤ÇÏ¿´À¸¸ç, ÃÖÀûÈ­ ÈÄ 5% ÀÌ»óÀÇ Á¡¼±·®¿ÀÂ÷ ÁöÁ¡ ¼ö 10% ¹Ì¸¸, Àý´ë Æò±Õ ¼±·®¿ÀÂ÷ 3% ¹Ì¸¸ÀÇ Çʸ§ ¼±·®°è¸¦ À§ÇÑ Á¤·®Àû Çã¿ë ±âÁØÀ» Á¦½ÃÇÏ¿´´Ù.

°á ·Ð: º» ¿¬±¸¿¡¼­ °³¹ßÇÑ ÃÖÀûÈ­¹ýÀº Çʸ§ ¼±·®°èÀÇ Ä¡¿ìħ ±³Á¤¿¡ ¸Å¿ì À¯È¿Çϸç, ÃÖÀûÈ­ ÈÄ Á¦½ÃµÈ Á¤·®Àû Çã¿ë ±âÁØÀº ȯÀÚº° IMRT QA¿¡ À¯¿ëÇÏ°Ô »ç¿ëµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµÈ´Ù.

Purpose: Film dosimetry as a part of patient specific intensity modulated radiation therapy quality assurance (IMRT QA) was performed to develop a new optimization method of film isocenter offset and to then suggest new quantitative criteria for film dosimetry.

Materials and Methods: Film dosimetry was performed on 14 IMRT patients with head and neck cancers. An optimization method for obtaining the local minimum was developed to adjust for the error in the film isocenter offset, which is the largest part of the systemic errors.

Results: The adjust value of the film isocenter offset under optimization was 1 mm in 12 patients, while only two patients showed 2 mm translation. The means of absolute average dose difference before and after optimization were 2.36 and 1.56%, respectively, and the mean ratios over a 5% tolerance were 9.67 and 2.88%. After optimization, the differences in the dose decreased dramatically. A low dose range cutoff (L-Cutoff) has been suggested for clinical application. New quantitative criteria of a ratio of over a 5%, but less than 10% tolerance, and for an absolute average dose difference less than 3% have been suggested for the verification of film dosimetry.

Conclusion: The new optimization method was effective in adjusting for the film dosimetry error, and the newly quantitative criteria suggested in this research are believed to be sufficiently accurate and clinically useful.

Å°¿öµå

IMRT Á¤µµ°ü¸®; Çʸ§ ¼±·®°è; ÃÖÀûÈ­; Çã¿ë ±âÁØ; IMRT QA; Film dosimetry; Optimization; Quantitative

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS